KEGG   DRUG: D02778Help
Entry
D02778                      Drug                                   

Name
Abciximab (genetical recombination) (JAN);
Abciximab (USAN/INN);
Reopro (TN)
Product
Formula
C2109H3243N553O674S15
Exact mass
47580.23
Mol weight
47609.5914
Activity
Monoclonal antibody [antithrombotic]
Remark
ATC code: 
Target
glycoprotein alphaIIb/beta3 (GPIIb/IIIa) [HSA:3674 3690] [KO:K06476 K06493]
  Pathway
hsa04510  Focal adhesion
hsa04512  ECM-receptor interaction  
 
Interaction
Drug interaction
Structure map
Antithrombosis agents
Brite
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
 B BLOOD AND BLOOD FORMING ORGANS
  B01 ANTITHROMBOTIC AGENTS
   B01A ANTITHROMBOTIC AGENTS
    B01AC Platelet aggregation inhibitors excl. heparin
     B01AC13 Abciximab
      D02778  Abciximab (genetical recombination) (JAN); Abciximab (USAN/INN)
Target-based classification of drugs [BR:br08310]
 Others
  Cell adhesion molecules (CAMs)
   glycoprotein alpha IIb/beta3 (GPIIb/IIIa) receptor
    Abciximab
     D02778  Abciximab (genetical recombination) (JAN); Abciximab (USAN/INN)
BRITE hierarchy
Other DBs
CAS: 
143653-53-6
PubChem: 
DrugBank: 
NIKKAJI: 

» Japanese version   » Back

DBGET integrated database retrieval system